Biofarm (LTS:0HTH) Cyclically Adjusted Revenue per Share: lei0.05 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0HTH Biofarm SA LTS:0HTH
69 GF Score
Price lei0.24
GF Value lei0.15
! 5 Warning Signs
View Full Analysis

What is Biofarm Cyclically Adjusted Revenue per Share?

Biofarm LTS:0HTH 69 Cyclically Adjusted Revenue per Share is lei0.05 as of Mar. 2026. GuruFocus rates LTS:0HTH with a GF Score™ of 69/100 and a GF Value™ of lei0.15. The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Biofarm's adjusted revenue per share for the three months ended in Mar. 2026 was lei0.094. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is lei0.05 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Biofarm's average Cyclically Adjusted Revenue Growth Rate was 7.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Biofarm was 1.40% per year. The lowest was 0.00% per year. And the median was 0.70% per year.

As of today (2026-07-28), Biofarm's current stock price is lei0.237. Biofarm's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was lei0.05. Biofarm's Cyclically Adjusted PS Ratio of today is 4.74.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Biofarm was 5.34. The lowest was 2.18. And the median was 2.81.


Biofarm  (LTS:0HTH) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Biofarm's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=0.237/0.05
=4.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Biofarm was 5.34. The lowest was 2.18. And the median was 2.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Biofarm Cyclically Adjusted Revenue per Share Related Terms


Biofarm Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Biofarm's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biofarm Cyclically Adjusted Revenue per Share Chart

Biofarm Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.10 0.08 0.08 0.08

Biofarm Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.08 0.08 0.08 0.05

LTS:0HTH vs ZTS, UTHR, VTRS: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Biofarm's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biofarm Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biofarm's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Biofarm's Cyclically Adjusted PS Ratio falls into.


LTS:0HTH
69GF Score
Biofarm SA LTS:0HTH
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biofarm Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Biofarm's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.094/330.2130*330.2130
=0.094

Current CPI (Mar. 2026) = 330.2130.

Biofarm Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 0.035 241.018 0.048
201609 0.038 241.428 0.052
201612 0.046 241.432 0.063
201703 0.038 243.801 0.051
201706 0.045 244.955 0.061
201709 0.040 246.819 0.054
201712 0.049 246.524 0.066
201803 0.044 249.554 0.058
201806 0.040 251.989 0.052
201809 0.048 252.439 0.063
201812 0.054 251.233 0.071
201903 0.049 254.202 0.064
201906 0.046 256.143 0.059
201909 0.042 256.759 0.054
201912 0.061 256.974 0.078
202003 0.065 258.115 0.083
202006 0.040 257.797 0.051
202009 0.051 260.280 0.065
202012 0.064 260.474 0.081
202103 0.063 264.877 0.079
202106 0.056 271.696 0.068
202109 0.062 274.310 0.075
202112 0.061 278.802 0.072
202203 0.077 287.504 0.088
202206 0.064 296.311 0.071
202209 0.071 296.808 0.079
202212 0.069 296.797 0.077
202303 0.097 301.836 0.106
202306 0.067 305.109 0.073
202309 0.068 307.789 0.073
202312 0.052 306.746 0.056
202403 0.073 312.332 0.077
202406 0.071 314.175 0.075
202409 0.091 315.301 0.095
202412 0.056 315.605 0.059
202503 0.096 319.799 0.099
202506 0.069 322.561 0.071
202509 0.102 324.800 0.104
202512 0.057 324.054 0.058
202603 0.094 330.213 0.094

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of lei0.05 mean?
Biofarm (LTS:0HTH) has a Cyclically Adjusted Revenue per Share of lei0.05 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Biofarm and its competitors.
Is Biofarm's Cyclically Adjusted Revenue per Share too high?
Biofarm's current Cyclically Adjusted Revenue per Share is lei0.05. Overall, Biofarm has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Biofarm's Cyclically Adjusted Revenue per Share compare to ZTS and UTHR?
Biofarm's Cyclically Adjusted Revenue per Share of lei0.05 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Biofarm and its competitors. Biofarm's current Cyclically Adjusted Revenue per Share is lei0.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biofarm stock overvalued right now?
Biofarm (LTS:0HTH) has a current Cyclically Adjusted Revenue per Share of lei0.05. The stock's GF Value™ is lei0.15, compared to a current price of lei0.24 — trading 58% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is lei0.05. Biofarm's overall GF Score™ is 69/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Biofarm (LTS:0HTH), the current Cyclically Adjusted Revenue per Share is lei0.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Biofarm (LTS:0HTH) Overvalued in 2026?

Based on GuruFocus' analysis, Biofarm stock appears to be overvalued. The current stock price of lei0.24 is trading 58% above its estimated GF Value™ of lei0.15.

Key valuation signals for LTS:0HTH:

  • Cyclically Adjusted Revenue per Share: lei0.05
  • GF Value™: lei0.15 vs. price of lei0.24 (58% above fair value)
  • GF Score™: 69/100 with 5 warning signs

No single metric tells the full story. See the LTS:0HTH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biofarm Business Description

Other Exchanges BIO:Romania
Address 99 Logofatul Tautu Street, Sector 3, Bucharest, ROU, 031212
Biofarm SA is a company engaged in production and marketing in the pharmaceutical sector. It is involved in the manufacture and wholesale of over-the-counter drugs, prescription medications, and dietary supplements. The firm's product portfolio includes pharmaceutical preparations for the digestive system, musculoskeletal system, immune stimulation, respiratory system, cold & flu symptoms, and venous circulation improvement, as well as multivitamins, antioxidants, antiseptics, disinfectants, and cosmetics, among others. Some of its brands are Triferment, Colebil, Cavit, Anghirol, Clorocalcin, and Bixtonim. Additionally, the company offers services, such as investment in research, promotion, and packaging.
69GF Score

Get the complete analysis for LTS:0HTH

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.24
Price
lei0.15
GF Value